MSN Pharmaceuticals Inc.

Cases where party is a Patent Asserter

Only "example" cases are shown here, for full list contact Shawn Miller

Cases where party is an Alleged Infringer

Displaying 1 - 13 of 13
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
1 Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al 1:24-cv-01193 D.Del.
Astex Therapeutics Ltd.
2 Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al 1:24-cv-01193 D.Del.
Novartis Pharmaceuticals Corporation
3 BAUSCH HEALTH IRELAND LIMITED et al v. MSN LABORATORIES PRIVATE LTD. et al 2:24-cv-07182 D.N.J.
  • 8 Product company
Bausch Health Ireland Limited
4 BAUSCH HEALTH IRELAND LIMITED et al v. MSN LABORATORIES PRIVATE LTD. et al 2:24-cv-07182 D.N.J.
  • 8 Product company
Salix Pharmaceuticals, Inc.
5 ESPERION THERAPEUTICS, INC. v. MICRO LABS USA, INC. et al 2:24-cv-05921 D.N.J.
  • 8 Product company
Esperion Therapeutics, Inc.
6 GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al 2:23-cv-00018 D.N.J.
  • 8 Product company
GW Research Limited
7 Exelixis, Inc. v. MSN Laboratories Private Limited et al 1:22-cv-00228 D.Del.
  • 13 Corporate-inventor-started company
Exelixis, Inc.
8 Exelixis, Inc. v. MSN Laboratories Private Limited et al 1:20-cv-00633 D.Del.
  • 8 Product company
Exelixis, Inc.
9 MERCK SHARP & DOHME B.V. et al v. MSN LABORATORIES PRIVATE LIMITED et al 2:20-cv-03314 D.N.J.
  • 8 Product company
Merck Sharp & Dohme
10 MERCK SHARP & DOHME B.V. et al v. MSN LABORATORIES PRIVATE LIMITED et al 2:20-cv-03314 D.N.J.
  • 8 Product company
Organon USA, Inc.
11 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al 1:18-cv-01689 D.Del.
  • 8 Product company
Boehringer Ingelheim International GMBH
12 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al 1:18-cv-01689 D.Del.
  • 8 Product company
Boehringer Ingelheim Corporation
13 Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al 1:18-cv-01689 D.Del.
  • 8 Product company
Boehringer Ingelheim Pharmaceuticals, Inc.